# Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke

> **NCT06645522** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Yi Yang** · enrollment: 1200 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Edaravone dexborneol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06645522
- **Lead sponsor:** Yi Yang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-30
- **Primary completion:** 2026-10-30
- **Final completion:** 2027-01-30
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06645522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06645522, "Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06645522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*